Erlotiniblet) and dehydration Patient Reports February 11, 2012

Erlotiniblet) Side Effects Report #5444139-0
Erlotiniblet) side effect was reported by a Physician from UNITED STATES on Aug 17, 2007. Male patient, 81 years of age, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotiniblet). After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood calcium decreased, blood chloride increased, blood creatinine increased, blood urea increased, dehydration, fatigue, hypernatraemia. Erlotiniblet) dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, PEMETREXED, INDAPAMIDE, LISINOPRIL, TERAZOSIN, POTASSIUM CHLORIDE, VITAMIN B12, FOLIC ACID. Patient was hospitalized. Patient recovered.